ArticleCancers2021

Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.

Kyu Sic You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.